SNORD82 (small nucleolar RNA, C/D box 82) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: SNORD82 (small nucleolar RNA, C/D box 82) Homo sapiens
Analyze
Symbol: SNORD82
Name: small nucleolar RNA, C/D box 82
RGD ID: 1352574
HGNC Page HGNC:10240
Description: Predicted to be involved in RNA processing. Predicted to be located in nucleolus.
Type: snorna
RefSeq Status: VALIDATED
Previously known as: RNU82; U82; Z25
RGD Orthologs
Mouse
Rat
Dog
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382231,460,368 - 231,460,442 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2231,460,371 - 231,460,440 (-)EnsemblGRCh38hg38GRCh38
GRCh372232,325,079 - 232,325,153 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 362232,325,079 - 232,325,153 (-)NCBINCBI36Build 36hg18NCBI36
Celera2226,101,432 - 226,101,506 (-)NCBICelera
Cytogenetic Map2q37.1NCBI
HuRef2224,166,562 - 224,166,636 (-)NCBIHuRef
CHM1_12232,330,895 - 232,330,969 (-)NCBICHM1_1
T2T-CHM13v2.02231,944,807 - 231,944,881 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process

Cellular Component
nucleolus  (IEA)

References

References - curated
# Reference Title Reference Citation
1. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:2394707   PMID:10524220   PMID:10684968   PMID:19446021  


Genomics

Comparative Map Data
SNORD82
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh382231,460,368 - 231,460,442 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2231,460,371 - 231,460,440 (-)EnsemblGRCh38hg38GRCh38
GRCh372232,325,079 - 232,325,153 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 362232,325,079 - 232,325,153 (-)NCBINCBI36Build 36hg18NCBI36
Celera2226,101,432 - 226,101,506 (-)NCBICelera
Cytogenetic Map2q37.1NCBI
HuRef2224,166,562 - 224,166,636 (-)NCBIHuRef
CHM1_12232,330,895 - 232,330,969 (-)NCBICHM1_1
T2T-CHM13v2.02231,944,807 - 231,944,881 (-)NCBIT2T-CHM13v2.0
Snord82
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39186,283,982 - 86,284,049 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl186,283,983 - 86,284,052 (-)EnsemblGRCm39 Ensembl
GRCm38186,356,260 - 86,356,327 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl186,356,261 - 86,356,330 (-)EnsemblGRCm38mm10GRCm38
MGSCv37188,252,835 - 88,252,902 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36188,187,431 - 88,187,498 (-)NCBIMGSCv36mm8
Celera189,321,164 - 89,321,231 (-)NCBICelera
Cytogenetic Map1C5NCBI
cM Map143.94NCBI
Snord82
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr8994,452,486 - 94,452,557 (-)NCBIGRCr8
mRatBN7.2987,004,515 - 87,004,586 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl987,004,515 - 87,004,586 (-)EnsemblmRatBN7.2 Ensembl
Rnor_6.0 Ensembl993,374,046 - 93,374,117 (-)NCBIRnor6.0rn6Rnor6.0
Cytogenetic Map9q35NCBI
LOC119866035
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Dog10K_Boxer_Tasha2543,895,186 - 43,895,251 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.02543,593,925 - 43,593,990 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl2543,593,925 - 43,593,990 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.12543,521,508 - 43,521,573 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.02543,364,353 - 43,364,418 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.02543,520,068 - 43,520,133 (-)NCBIUU_Cfam_GSD_1.0


Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 2q32.3-37.3(chr2:194898783-236473913)x3 copy number gain See cases [RCV000051119] Chr2:194898783..236473913 [GRCh38]
Chr2:195763507..237382556 [GRCh37]
Chr2:195471752..237047295 [NCBI36]
Chr2:2q32.3-37.3
pathogenic
GRCh38/hg38 2q36.3-37.2(chr2:227343278-235339168)x1 copy number loss See cases [RCV000052638] Chr2:227343278..235339168 [GRCh38]
Chr2:228207994..236247812 [GRCh37]
Chr2:227916238..235912551 [NCBI36]
Chr2:2q36.3-37.2
pathogenic
GRCh38/hg38 2q37.1-37.3(chr2:231375505-242065208)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052639]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052639]|See cases [RCV000052639] Chr2:231375505..242065208 [GRCh38]
Chr2:232240216..243007359 [GRCh37]
Chr2:231948460..242656032 [NCBI36]
Chr2:2q37.1-37.3
pathogenic
GRCh38/hg38 2q36.3-37.3(chr2:226978129-236886599)x1 copy number loss See cases [RCV000052637] Chr2:226978129..236886599 [GRCh38]
Chr2:227842845..237795242 [GRCh37]
Chr2:227551089..237459981 [NCBI36]
Chr2:2q36.3-37.3
pathogenic
GRCh38/hg38 2q32.2-37.3(chr2:188818195-242065208)x3 copy number gain See cases [RCV000052958] Chr2:188818195..242065208 [GRCh38]
Chr2:189682921..243007359 [GRCh37]
Chr2:189391166..242656032 [NCBI36]
Chr2:2q32.2-37.3
pathogenic
GRCh38/hg38 2q32.2-37.3(chr2:190310736-241892770)x3 copy number gain See cases [RCV000052959] Chr2:190310736..241892770 [GRCh38]
Chr2:191175462..242834921 [GRCh37]
Chr2:190883707..242483594 [NCBI36]
Chr2:2q32.2-37.3
pathogenic
GRCh38/hg38 2q32.3-37.3(chr2:193122313-241074980)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052960]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052960]|See cases [RCV000052960] Chr2:193122313..241074980 [GRCh38]
Chr2:193987039..242014395 [GRCh37]
Chr2:193695284..241663068 [NCBI36]
Chr2:2q32.3-37.3
pathogenic
GRCh38/hg38 2q36.1-37.3(chr2:223992431-242126245)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052972]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052972]|See cases [RCV000052972] Chr2:223992431..242126245 [GRCh38]
Chr2:224857148..243059659 [GRCh37]
Chr2:224565392..242717069 [NCBI36]
Chr2:2q36.1-37.3
pathogenic
GRCh38/hg38 2q36.3-37.3(chr2:227803148-242086301)x3 copy number gain See cases [RCV000052973] Chr2:227803148..242086301 [GRCh38]
Chr2:228667864..243028452 [GRCh37]
Chr2:228376108..242677125 [NCBI36]
Chr2:2q36.3-37.3
pathogenic
GRCh38/hg38 2q36.3-37.3(chr2:228723579-241404867)x3 copy number gain See cases [RCV000134169] Chr2:228723579..241404867 [GRCh38]
Chr2:229588295..242344282 [GRCh37]
Chr2:229296539..241992955 [NCBI36]
Chr2:2q36.3-37.3
pathogenic
GRCh38/hg38 2q34-37.3(chr2:210579676-242126245)x3 copy number gain See cases [RCV000135934] Chr2:210579676..242126245 [GRCh38]
Chr2:211444400..243059659 [GRCh37]
Chr2:211152645..242717069 [NCBI36]
Chr2:2q34-37.3
pathogenic
GRCh38/hg38 2q36.3-37.2(chr2:228014149-234976424)x3 copy number gain See cases [RCV000136967] Chr2:228014149..234976424 [GRCh38]
Chr2:228878865..235885068 [GRCh37]
Chr2:228587109..235549807 [NCBI36]
Chr2:2q36.3-37.2
pathogenic
GRCh38/hg38 2q32.2-37.3(chr2:189436149-241841232)x3 copy number gain See cases [RCV000142307] Chr2:189436149..241841232 [GRCh38]
Chr2:190300875..242783384 [GRCh37]
Chr2:190009120..242432057 [NCBI36]
Chr2:2q32.2-37.3
pathogenic
GRCh38/hg38 2q35-37.3(chr2:218101759-242126245)x3 copy number gain See cases [RCV000143216] Chr2:218101759..242126245 [GRCh38]
Chr2:218966482..243059659 [GRCh37]
Chr2:218674727..242717069 [NCBI36]
Chr2:2q35-37.3
pathogenic
GRCh37/hg19 2q37.1(chr2:232215111-235593473)x1 copy number loss See cases [RCV000446723] Chr2:232215111..235593473 [GRCh37]
Chr2:2q37.1
likely pathogenic
GRCh37/hg19 2q35-37.3(chr2:219966808-237815985)x3 copy number gain See cases [RCV000448049] Chr2:219966808..237815985 [GRCh37]
Chr2:2q35-37.3
pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384) copy number gain See cases [RCV000512056] Chr2:12771..242783384 [GRCh37]
Chr2:2p25.3-q37.3
pathogenic
GRCh37/hg19 2q34-37.3(chr2:213518431-242783384)x3 copy number gain See cases [RCV000512009] Chr2:213518431..242783384 [GRCh37]
Chr2:2q34-37.3
pathogenic
GRCh37/hg19 2q36.1-37.3(chr2:222077224-239394441)x3 copy number gain See cases [RCV000511816] Chr2:222077224..239394441 [GRCh37]
Chr2:2q36.1-37.3
pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3 copy number gain See cases [RCV000511212] Chr2:12771..242783384 [GRCh37]
Chr2:2p25.3-q37.3
pathogenic
GRCh37/hg19 2q35-37.3(chr2:219225872-242016876)x3 copy number gain not provided [RCV000682170] Chr2:219225872..242016876 [GRCh37]
Chr2:2q35-37.3
pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:14238-243048760)x3 copy number gain not provided [RCV000752802] Chr2:14238..243048760 [GRCh37]
Chr2:2p25.3-q37.3
pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:15672-243101834)x3 copy number gain not provided [RCV000752804] Chr2:15672..243101834 [GRCh37]
Chr2:2p25.3-q37.3
pathogenic
GRCh37/hg19 2q34-37.3(chr2:210779657-239879183)x3 copy number gain See cases [RCV000790568] Chr2:210779657..239879183 [GRCh37]
Chr2:2q34-37.3
pathogenic
GRCh37/hg19 2q36.3-37.3(chr2:230814690-242783384)x3 copy number gain not provided [RCV001007519] Chr2:230814690..242783384 [GRCh37]
Chr2:2q36.3-37.3
pathogenic
GRCh37/hg19 2q31.2-37.3(chr2:178397959-243007457)x3 copy number gain See cases [RCV001263052] Chr2:178397959..243007457 [GRCh37]
Chr2:2q31.2-37.3
pathogenic
GRCh37/hg19 2p25.3-q37.3(chr2:1-243199373) copy number gain Mosaic trisomy 2 [RCV002280628] Chr2:1..243199373 [GRCh37]
Chr2:2p25.3-q37.3
pathogenic
GRCh37/hg19 2q35-37.3(chr2:219606537-239217703) copy number loss not specified [RCV002053285] Chr2:219606537..239217703 [GRCh37]
Chr2:2q35-37.3
pathogenic
GRCh37/hg19 2q37.1(chr2:232215111-235593473) copy number loss not specified [RCV002053294] Chr2:232215111..235593473 [GRCh37]
Chr2:2q37.1
likely pathogenic
GRCh37/hg19 2q36.3-37.1(chr2:228807574-235475892) copy number loss not specified [RCV002053291] Chr2:228807574..235475892 [GRCh37]
Chr2:2q36.3-37.1
pathogenic
NC_000002.11:g.(?_231033840)_(234978657_?)dup duplication Joubert syndrome 22 [RCV001877690]|Perlman syndrome [RCV001877689] Chr2:231033840..234978657 [GRCh37]
Chr2:2q37.1
uncertain significance
GRCh37/hg19 2q35-37.3(chr2:218376403-242783384)x3 copy number gain not provided [RCV003484087] Chr2:218376403..242783384 [GRCh37]
Chr2:2q35-37.3
pathogenic
Single allele duplication not provided [RCV003448672] Chr2:230077026..243049549 [GRCh37]
Chr2:2q36.3-37.3
pathogenic
GRCh37/hg19 2q36.2-37.3(chr2:225995545-237594511)x3 copy number gain not provided [RCV003484091] Chr2:225995545..237594511 [GRCh37]
Chr2:2q36.2-37.3
pathogenic
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:61
Count of miRNA genes:61
Interacting mature miRNAs:61
Transcripts:ENST00000365530
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
D2S1557E  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372232,325,212 - 232,325,422UniSTSGRCh37
Build 362232,033,456 - 232,033,666RGDNCBI36
Celera2226,101,565 - 226,101,775RGD
Cytogenetic Map2q37.1UniSTS
HuRef2224,166,695 - 224,166,905UniSTS
PMC207647P1  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh372232,326,295 - 232,326,627UniSTSGRCh37
Build 362232,034,539 - 232,034,871RGDNCBI36
Celera2226,102,648 - 226,102,980RGD
Cytogenetic Map2q37.1UniSTS
HuRef2224,167,778 - 224,168,110UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High
Medium 1 5 3 10 1 1
Low 81 12 49 33 234 37 96 45 69 52 99 98 4 8 3
Below cutoff 15 1 5 7 13 5 6 11 16 1 2

Sequence


RefSeq Acc Id: ENST00000365530
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl2231,460,371 - 231,460,440 (-)Ensembl
RefSeq Acc Id: NR_004398
RefSeq Status: VALIDATED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh382231,460,368 - 231,460,442 (-)NCBI
GRCh372232,325,079 - 232,325,153 (-)RGD
Celera2226,101,432 - 226,101,506 (-)RGD
HuRef2224,166,562 - 224,166,636 (-)ENTREZGENE
CHM1_12232,330,895 - 232,330,969 (-)NCBI
T2T-CHM13v2.02231,944,807 - 231,944,881 (-)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:10240 AgrOrtholog
COSMIC SNORD82 COSMIC
Ensembl Genes ENSG00000202400 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000365530 ENTREZGENE
GTEx ENSG00000202400 GTEx
HGNC ID HGNC:10240 ENTREZGENE
Human Proteome Map SNORD82 Human Proteome Map
NCBI Gene 25826 ENTREZGENE
OMIM 611133 OMIM
PharmGKB PA34607 PharmGKB
RNAcentral URS00005160A3 RNACentral